Full Text View
Tabular View
No Study Results Posted
Related Studies
Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer
This study is ongoing, but not recruiting participants.
Study NCT00004256   Information provided by National Cancer Institute (NCI)
First Received: January 28, 2000   Last Updated: August 19, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Head and Neck Cancer
Oral Complications
Radiation Toxicity
Additional conditions recognized in this trial
Head and Neck Neoplasms
Laryngeal Neoplasms
Mucositis
More general conditions related to this trial
Digestive System Diseases
Gastroenteritis
Gastrointestinal Diseases
Laryngeal Diseases
Mouth Diseases
Neoplasms
Neoplasms by Site
Otorhinolaryngologic Diseases
Otorhinolaryngologic Neoplasms
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Stomatognathic Diseases
Interventions listed in this trial
sargramostim
quality-of-life assessment
radiation therapy
Sponsors listed in this trial
Royal Marsden - London


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services